Iron-binding compounds impair Pseudomonas aeruginosa biofilm formation, especially under anaerobic conditions

Journal of Medical Microbiology

Volumn 58, Issue 6, 2009, Pages 765-773

  O'May, Che Y ^a   Sanderson, Kevin ^a   Roddam, Louise F ^a   Kirov, Sylvia M ^b   Reid, David W ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2,2' BIPYRIDINE; DEFEROXAMINE MESYLATE; EDETIC ACID; IRON; IRON CHELATING AGENT; LACTOFERRIN; N,N' ETHYLENEDIAMINEDIACETIC ACID; PENTETIC ACID; TRANSFERRIN; UNCLASSIFIED DRUG;

ANAEROBIC METABOLISM; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BIOFILM; CONTROLLED STUDY; CYSTIC FIBROSIS; HUMAN; HUMAN TISSUE; IRON BINDING CAPACITY; IRON THERAPY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SPUTUM ANALYSIS;

AEROBIOSIS; ANAEROBIOSIS; BIOFILMS; CHELATING AGENTS; CULTURE MEDIA; CYSTIC FIBROSIS; EDETIC ACID; HUMANS; IRON; LUNG; PENTETIC ACID; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 66449094685     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.004416-0     Document Type: Article

References (32)

1. Banin, E., Brady, K. M. & Greenberg, E. P. (2006). Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm. Appl Environ Microbiol 72, 2064-2069.
2. Brock, J. H., Liceaga, J. & Kontoghiorghes, G. J. (1988). The effect of synthetic iron chelators on bacterial growth in human serum. FEMS Microbiol Immunol 1, 55-60. (Pubitemid 18114398)
3. Ceri, H., Olson, M. E., Stremick, C., Read, R. R., Morick, D. & Buret, A. (1999). The Calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 37, 1771-1776. (Pubitemid 29235221)
4. Costerton, J. W. (2002). Anaerobic biofilm infections in cystic fibrosis. Mol Cell 10, 699-700. (Pubitemid 35335624)
5. Heydorn, A., Nielsen, A. T., Hentzer, M., Sternberg, C., Givskov, M., Ersboll, B. K. & Molin, S. (2000). Quantification of biofilm structures by the novel computer program COMSTAT. Microbiology 146, 2395-2407.
6. Holloway, B. W. (1955). Genetic recombination in Pseudomonas aeruginosa. J Gen Microbiol 13, 572-581.
7. Kaneko, Y., Thoendel, M., Olakanmi, O., Britigan, B. E. & Singh, P. K. (2007). The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity. J Clin Invest 117, 877-888. (Pubitemid 46556744)
8. Kirov, S. M., Webb, J. S., O'May, C. Y., Reid, D. W., Woo, J. K., Rice, S. A. & Kjelleberg, S. (2007). Biofilm differentiation and dispersal in mucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Microbiology 153, 3264-3274. (Pubitemid 47629532)
9. Liu, Z. D. & Hider, R. C. (2002). Design of clinically useful iron(III)-selective chelators. Med Res Rev 22, 26-64. (Pubitemid 34023572)
10. Lyczak, J. B., Cannon, C. L. & Pier, G. B. (2002). Lung infections associated with cystic fibrosis. Clin Microbiol Rev 15, 194-222. (Pubitemid 34303763)
11. Meyer, J. M. & Abdallah, M. A. (1978). The fluorescent pigment of Pseudomonas fluorescens: biosynthesis, purification and physiochemical properties. J Gen Microbiol 107, 319-328. (Pubitemid 8397930)
12. Miller, J. (1972). Experiments in Molecular Genetics. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
13. Moreau-Marquis, S., Bomberger, J. M., Anderson, G. G., Swiatecka-Urban, A., Ye, S., O'Toole, G. A. & Stanton, B. A. (2008). The DeltaF508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability. Am J Physiol Lung Cell Mol Physiol 295, L25-L37.
14. Musk, D. J., Jr & Hergenrother, P. J. (2008). Chelated iron sources are inhibitors of Pseudomonas aeruginosa biofilms and distribute efficiently in an in vitro model of drug delivery to the human lung. J Appl Microbiol 105, 380-388.
15. Musk, D. J., Banko, D. A. & Hergenrother, P. J. (2005). Iron salts perturb biofilm formation and disrupt existing biofilms of Pseudomonas aeruginosa. Chem Biol 12, 789-796. (Pubitemid 41009158)
16. Nealson, K. H. & Saffarini, D. (1994). Iron and manganese in anaerobic respiration: environmental significance, physiology, and regulation. Annu Rev Microbiol 48, 311-343. (Pubitemid 24334100)
17. O'May, C. Y., Reid, D. W. & Kirov, S. M. (2006). Anaerobic culture conditions favor biofilm-like phenotypes in Pseudomonas aeruginosa isolates from patients with cystic fibrosis. FEMS Immunol Med Microbiol 48, 373-380. (Pubitemid 44736576)
18. O'Toole, G. A., Pratt, L. A., Watnick, P. I., Newman, D. K., Weaver, V. B. & Kolter, R. (1999). Genetic approaches to study of biofilms. Methods Enzymol 310, 91-109. (Pubitemid 129748378)
19. Patriquin, G. M., Banin, E., Gilmour, C., Tuchman, R., Greenberg, E. P. & Poole, K. (2008). Influence of quorum sensing and iron on twitching motility and biofilm formation in Pseudomonas aeruginosa. J Bacteriol 190, 662-671.
20. Reid, D. W., Lam, Q. T., Schneider, H. & Walters, E. H. (2004). Airway iron and iron-regulatory cytokines in cystic fibrosis. Eur Respir J 24, 286-291. (Pubitemid 39139798)
21. Reid, D. W., Carroll, V., O'May, C., Champion, A. & Kirov, S. M. (2007). Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis. Eur Respir J 30, 286-292. (Pubitemid 47194181)
22. Singh, P. K., Schaefer, A. L., Parsek, M. R., Moninger, T. O., Welsh, M. J. & Greenberg, E. P. (2000). Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407, 762-764.
23. Singh, P. K., Parsek, M. R., Greenberg, E. P. & Welsh, M. J. (2002). A component of innate immunity prevents bacterial biofilm development. Nature 417, 552-555. (Pubitemid 34595922)
24. Stewart, P. S. & Franklin, M. J. (2008). Physiological heterogeneity in biofilms. Nat Rev Microbiol 6, 199-210.
25. Stites, S. W., Walters, B., O'Brien-Ladner, A. R., Bailey, K. & Wesselius, L. J. (1998). Increased iron and ferritin content of sputum from patients with cystic fibrosis or chronic bronchitis. Chest 114, 814-819. (Pubitemid 28433746)
26. Takase, H., Nitanai, H., Hoshino, K. & Otani, T. (2000). Impact of siderophore production on Pseudomonas aeruginosa infections in immunosuppressed mice. Infect Immun 68, 1834-1839. (Pubitemid 30164806)
27. Vasil, M. L. (2007). How we learnt about iron acquisition in Pseudomonas aeruginosa: a series of very fortunate events. Biometals 20, 587-601. (Pubitemid 46776581)
28. Vasil, M. L. & Ochsner, A. (1999). The response of Pseudomonas aeruginosa to iron: genetics, biochemistry and virulence. Mol Microbiol 34, 399-413. (Pubitemid 29507302)
29. Webb, J. S., Thompson, L. S., James, S., Charlton, T., Tolker-Nielsen, T., Koch, B., Givskov, M. & Kjelleberg, S. (2003). Cell death in Pseudomonas aeruginosa biofilm development. J Bacteriol 185, 4585-4592. (Pubitemid 36890507)
30. Weinberg, E. D. (2004). Suppression of bacterial biofilm formation by iron limitation. Med Hypotheses 63, 863-865. (Pubitemid 39370008)
31. Worlitzsch, D., Tarran, R., Ulrich, M., Schwab, U., Cekici, A., Meyer, K. C., Birrer, P., Bellon, G., Berger, J. & other authors (2002). Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 109, 317-325.
32. Yang, L., Barken, K. B., Skindersoe, M. E., Christensen, A. B., Givskov, M. & Tolker-Nielsen, T. (2007). Effects of iron on DNA release and biofilm development by Pseudomonas aeruginosa. Microbiology 153, 1318-1328. (Pubitemid 46779988)